More than producing documents, we're helping move your program forward.
End-to-end support
Coordinated writing, operations, and submission leadership
Global regulatory submission expertise
Experience across FDA, EMA, and international agencies
Integrated teams
Seamless collaboration across functions and stakeholders
Faster timelines
Structured processes that reduce delays and rework
HOW IT WORKS
However much support you need, one workstream or the whole program, here's how we move a submission forward:
We start with the plan
Timelines get mapped, and writing, operations, and cross-functional teams start working from the same page instead of separately.
Writers take it from there
Clear, compliant documentation across clinical, nonclinical, CMC, and beyond.
Nothing moves forward without QC
Every document gets checked and formatted before it advances, catching the kind of issues that normally turn into late-stage rework.
Operations handles the technical side
eCTD publishing, validation, and submission management, so the paperwork matches the science.
For major milestones, we lead
IND, NDA, BLA, MAA, we coordinate so every workstream lands together, not in pieces.
It doesn't stop at filing
Global disclosure requirements, aggregate safety reporting, we stay in it.
Veristat Expertise
Veristat Expertise in Regulatory Agency Meeting Preparations
More than producing documents, we're helping move your program forward.
Therapeutic nuance, not templates
Regulatory writing isn't one-size-fits-all, and treating it that way shows. We write with the depth your therapeutic area actually requires.
Fluent in plain language
Lay summary and plain-language requirements have reshaped what "clear" documentation means. Our team already writes for that world, work that holds up with regulators and makes sense to patients.
Built for complexity
Rolling submissions, shifting deadlines, high-volume workstreams, that's usually when the work gets more interesting to us, not less. Our process holds up under pressure without cutting corners on quality.
Scalable by design
Whether it's a single document or an entire submission, we scale to match the scope, without losing the coordination that keeps everything moving together.
veristat by the numbers
Real experience behind every complex program we take on
200+ Regulatory Experts
Regulatory writers, editors, and submission specialists across disciplines
Global Submission Experience
Supporting submissions to FDA, EMA, and regulatory agencies worldwide
Behind Recent FDA Approvals
Teams like ours have supported many recently approved therapies
BLA Delivered Ahead of Schedule
Rolling submission completed successfully despite shifting development timelines
Veristat's Offerings
End-to-End Support Across the Submission Lyfecycle
Global regulatory expertise
Clear, compliant documentation across clinical, nonclinical, CMC, and beyond.
We work alongside sponsors at critical points in the submission process, when timelines tighten, coordination gets complicated, and every workstream needs to move together.
Approaching database lock and preparing for submission
Managing high-volume writing across multiple workstreams
Preparing for IND, NDA, BLA, or MAA milestones
Navigating global regulatory and disclosure requirements
Clear, Inclusive, Human: The Lay Language Shift Reshaping Clinical Communications
Learn more →
Delivered a rolling BLA submission ahead of schedule despite shifting timelines
Learn more →
Best Practices for Safety Narrative Writing in Clinical Research
Learn more →
Turn finalized data into a submission-ready story.
Database lock is a milestone, not the finish line. Veristat brings regulatory writing, submission strategy, operations, and cross-functional expertise together to turn your finalized data into a cohesive regulatory story, keeping every workstream aligned as your program moves toward filing and regulatory review.
Share where your program stands, and one of our regulatory strategists will follow up.
Regulatory writing support spans documentation across the full submission lifecycle, including clinical, nonclinical, and CMC writing, submission leadership for IND, NDA, BLA, and MAA milestones, clinical disclosure and transparency, regulatory operations like eCTD publishing, safety and pharmacovigilance documentation, and document quality management.
Data management focuses on collecting, cleaning, and organizing clinical trial data through database design and quality control, while biostatistics focuses on analyzing that data to answer the trial's scientific and regulatory questions.
SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) are industry-standard data structures required by regulatory agencies like the FDA. Formatting trial data into these standards is what makes a submission's data package usable and reviewable by regulators.
FSP (Functional Service Provider) is a flexible staffing model where a sponsor engages dedicated biometrics experts, such as programmers or biostatisticians, to integrate directly into their team, rather than outsourcing an entire function. It's often used when a sponsor needs to scale specific expertise quickly without building out a full internal department.
A DMC is an independent group that periodically reviews accumulating trial data, often unblinded, to monitor patient safety and trial integrity. It provides an added layer of oversight that helps protect patients while maintaining the statistical validity of the trial.
